Header Logo

Connection

DAVID G MENTER to Maximum Tolerated Dose

Back to Details
This is a "connection" page, showing publications DAVID G MENTER has written about Maximum Tolerated Dose.
DAVID G MENTER
Connection Strength
0.027
Maximum Tolerated Dose
  1. Dual Inhibition of EGFR and c-Src by Cetuximab and Dasatinib Combined with FOLFOX Chemotherapy in Patients with Metastatic Colorectal Cancer. Clin Cancer Res. 2017 Aug 01; 23(15):4146-4154.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.